Viewing Study NCT02598960


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-03-15 @ 5:58 AM
Study NCT ID: NCT02598960
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2015-10-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords: